Clinical Outcomes Among Patients Treated With Stereotactic Body Radiation Therapy to Femur Metastases for Oligometastatic Disease Control or Reirradiation: Results From a Large Single-Institution Experience

Clinical Outcomes Among Patients Treated With Stereotactic Body Radiation Therapy to Femur Metastases for Oligometastatic Disease Control or Reirradiation: Results From a Large Single-Institution Experience

Purpose: There are limited data regarding outcomes after stereotactic body radiation therapy (SBRT) for femur metastases, which was an exclusion criteria for the Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers (SABR-COMET) trial. We aimed to characterize...

Full description

Bibliographic Details
Main Authors: Caitlyn Kwan, BS, Yu-Hui Chen, MS, MPH, Joseph H. Killoran, PhD, Marco Ferrone, MD, Karen J. Marcus, MD, Shyam Tanguturi, MD, Tracy A. Balboni, MD, MPH, Alexander Spektor, MD, PhD, Mai Anh Huynh, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109424000022

Internet

http://www.sciencedirect.com/science/article/pii/S2452109424000022

Similar Items